This study proposes a unified framework to classify targets for precision cancer medicine based on clinical evidence of utility, to aid oncologists in prioritising potential targets for clinical use when receiving reports of broad gene sequencing panels, and facilitate implementation of precision medicine in the clinical management of cancer….
Cancer Type: Pan Tumor
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was established to advance precision oncology in Hong Kong. A multicenter retrospective study investigated the feasibility of the HKU-HKSH MTB in determining genome-guided therapy for treatment-refractory solid cancers in Hong Kong….
The right tools at the right time: Liquid Biopsy enters the clinic
The field of clinical oncology continues to see drastic advancements with non-invasive techniques, such as liquid biopsy being adopted for diagnosing and monitoring cancers in place of more invasive methods. . However, several limitations still hamper the implementation of liquid biopsy in clinical practice. Join the webinar to learn how liquid biopsies may help with treatment selection and monitoring of cancer treatment outcomes and the current challenges limiting clinical practice adoption….
Digital Tools to Drive NGS Clinical Application for the Future
The growing amount of clinical data available for each patient, clinicians need to manage massive genomic information, histological analysis tools, and clinical trials and publications. They must depend on connecting with other clinicians and digital tools to support decision making. Join the webinar to hear from Assoc. Prof. Jason CH Hsieh and Assoc. Prof. Svetlana Cherepanoff on the potential of using digital clinical analysis and communication tools to help make optimal patient decisions….
NGS and precision oncology in Hong Kong: insights from Dr Lam Tai-Chung
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seemingly terminal patients. …
Next-generation sequencing (NGS) drives precision oncology in Singapore
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root….